Trial Profile

A Randomized Single Dose Crossover Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of CTP-692 Versus D-Serine

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 04 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Deutarserine (Primary) ; D-serine
Indications Schizophrenia
Focus Adverse reactions; Pharmacokinetics
Sponsors Concert Pharmaceuticals

Most Recent Events

12 Jun 2019 According to a Concert Pharmaceuticals media release, data from this tria was presented as a poster at the 2019 American Society of Clinical Psychopharmacology Annual Meeting in Scottsdale, AZ.
12 Jun 2019 Results published in the Concert Pharmaceuticals Media Release
02 May 2019 According to a Concert Pharmaceuticals media release, results will be presented during the poster session at The American Society of Clinical Psychopharmacology (ASCP) annual meeting May 28-31, 2019.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com